Loading…
Lobbying Spend
—
Filings
21
Firms Hired
1
Active Period
2015–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Further Consolidated Appropriations Act, 2020
2019 · fourth_quarter · Firm: THE MCMANUS GROUP
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, H.R. 3429, the HEARTS and Rural Relief Act, and H.R. 1865, the Further Consolidated Appropriations Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1865
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, H.R. 3429, the HEARTS and Rural Relief Act, and H.R. 1865, the Further Consolidated Appropriations Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2371
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, H.R. 3429, the HEARTS and Rural Relief Act, and H.R. 1865, the Further Consolidated Appropriations Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3429
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2371
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3429
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2371
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3429
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · fourth_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2557
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6886
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · fourth_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: S. 2067
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · third_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2557
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6886
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · third_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: — · Firm income: $20,000
Matched citations: S. 2067
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · second_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2557
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · second_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: S. 2067
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for Medicare coverage of prostate cancer diagnostic test in H.R. 1892 - Bipartisan Budget Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1892
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · first_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for Medicare coverage of prostate cancer diagnostic test in H.R. 1892 - Bipartisan Budget Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2557
Prostate Cancer Misdiagnosis Elimination Act of 2017
2018 · first_quarter · Firm: THE MCMANUS GROUP
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for Medicare coverage of prostate cancer diagnostic test in H.R. 1892 - Bipartisan Budget Act.
Client expense: — · Firm income: $20,000
Matched citations: S. 2067
Prostate Cancer Misdiagnosis Elimination Act of 2017
2017 · fourth_quarter · Firm: THE MCMANUS GROUP
Medicare coverage of diagnostic test. Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2557
Prostate Cancer Misdiagnosis Elimination Act of 2017
2017 · fourth_quarter · Firm: THE MCMANUS GROUP
Medicare coverage of diagnostic test. Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: S. 2067
Prostate Cancer Misdiagnosis Elimination Act of 2017
2017 · third_quarter · Firm: THE MCMANUS GROUP
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2557
Prostate Cancer Misdiagnosis Elimination Act of 2017
2017 · second_quarter · Firm: THE MCMANUS GROUP
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2557
Prostate Cancer Misdiagnosis Elimination Act of 2016
2016 · fourth_quarter · Firm: THE MCMANUS GROUP
Medicare coverage of diagnostic test. Support for H.R.5763 - Prostate Cancer Misdiagnosis Elimination Act of 2016.
Client expense: — · Firm income: $20,000
Matched citations: H.R.5763
Prostate Cancer Misdiagnosis Elimination Act of 2016
2016 · third_quarter · Firm: THE MCMANUS GROUP
Medicare coverage of diagnostic test. Support for H.R.5763 - Prostate Cancer Misdiagnosis Elimination Act of 2016.
Client expense: — · Firm income: $20,000
Matched citations: H.R.5763
Source: Senate LDA